Metals Australia (ASX:MLS) is progressing a diverse portfolio of critical and strategic mineral projects across Australia and Canada, with new exploration and development opportunities emerging alongside its flagship Lac Carheil Graphite Project. CEO Paul Ferguson joins The Stock Network’s Lel Smits to discuss the company’s expanding exploration pipeline, the emerging Manindi Vanadium-Titanium-Magnetite opportunity and the key milestones ahead across its portfolio.

🪓 Expanding the exploration pipeline
🛘 Manindi VTM opportunity
⚒️ From exploration to development

Mesoblast (ASX:MSB, Nasdaq:MESO) has delivered a strong FY2026 result, with Ryoncil® driving a major lift in revenue and the company moving closer to a sustainable commercial model. At the same time, cash discipline has improved while Mesoblast continues to invest in its pipeline and next phase of growth. With Ryoncil® gaining traction, plans to expand into the adult market and its Phase 3 chronic low back pain trial complete, Mesoblast is entering its next stage of growth. Mesoblast CEO and Managing Director Dr Silviu Itescu joins Lel Smits from The Stock Network to discuss the results, Ryoncil® growth and key catalysts ahead.

🚀 FY26 Financial results highlights
💉 Ryoncil®: building commercial momentum
🧬 Unlocking the adult market
⚕️ The next big catalyst

Noxopharm (ASX:NOX) has generated new preclinical data showing its Sofra™ technology can activate immune cells in response to dying cancer cells. The study found that dying cancer cells alone did not trigger an immune response, but combining them with Noxopharm’s TLR8-amplifying oligonucleotide drug produced a strong immune activation, reaching seven times the untreated level. The result strengthens the case for using Sofra™ alongside treatments such as chemotherapy and radiotherapy, while moving Noxopharm’s oncology program closer to in vivo proof-of-concept studies. CEO Olivier Laczka speaks with The Stock Network`s Lel Smits about activating immune cells against dying cancer cells, producing a substantial immune response, complementing chemotherapy, radiotherapy, checkpoint inhibitors and mRNA vaccines, and moving Sofra™ towards in vivo studies.

🧬 Activating immune cells against dying cancer cells
🛡️Delivering a seven-fold immune response
⚕️ Moving Sofra™ towards in vivo studies

As AI and computing reshape how investors access, analyse and act on information, the human edge remains critical to long-term investing. Teaminvest Private Group (ASX) owns the Teaminvest investing platform, bringing together self-directed investors who collectively deploy more than $3 billion into equities. Ahead of presenting at the Australian Shareholders’ Association Investor Summit - Future fortunes, human edge, investing in the age of AI - Head of Funds Management and Education, Sanjee Narendran, joins Lel Smits from The Stock Network to discuss the human edge in investing as AI continues to transform markets.

🧠 The human edge in an AI world
📈 Beyond the data: judgement, patience and discipline

Australian Shareholders’ Association Investor Summit
🗓 Mon 14 - Tue 15 September 2026
📍 The Langham Hotel, Gold Coast

49 Metals (ASX:49M) has completed its maiden drilling program at Gold Mountain in Nevada, with all 22 holes returning gold and/or silver mineralisation. The latest results include the project’s thickest gold intersection to date, 170.7m at 0.9g/t gold, alongside high-grade zones including 10.7m at 8.4g/t and 3.0m at 20.0g/t. With the Adit Zone remaining open in all directions, CEO Phil Carter joins The Stock Network’s Lel Smits to discuss the results and plans to unlock Gold Mountain’s scale.

🇺🇲 Unlocking Gold Mountain’s scale in Nevada, U.S.A.
⛏️ Extending the high-grade corridor
🔩 Building the next drilling campaign

Manuka Resources (ASX:MKR) has restarted gold production at its Wonawinta processing facility, marking the company’s return to precious metals production with more than 50,000 tonnes of Mt Boppy gold ore already stockpiled and ready for processing.

⛏️ Gold production restarts: Manuka has recommenced processing of ore from its 100%-owned Mt Boppy gold mine, with more than 50,000 tonnes grading approximately 1.1g/t gold already delivered to Wonawinta.
🏭 Plant recommissioned: The restart follows a five-month recommissioning program that included upgrades to power generation, laboratory facilities and key processing plant components. Manuka Resources is targeting 125,000–140,000 tonnes of Mt Boppy ore to be processed over the next three months.
🥈 Silver is next: Manuka Resources is continuing upgrades to the Wonawinta facility, including installation of a new de-slime circuit designed to improve processing of clay-rich silver ores. Silver production is targeted to commence in the fourth quarter of calendar year 2026, after which gold and silver ores are expected to be processed simultaneously.

“Today marks an important milestone for Manuka as we commence the restart of gold production at Wonawinta following an intensive recommissioning program.” – Dennis Karp, Manuka Resources Executive Chairman

As AI transforms drug discovery and development, the opportunity to harness new technology while keeping patients, scientific outcomes and long-term shareholder value at the centre is evolving. Starpharma (ASX:SPL, US OTC:SPHRY) is advancing its dendrimer technology across areas including oncology while navigating this rapidly changing biotech landscape. Ahead of presenting at Australian Shareholders’ Association Investor Summit - Future fortunes, human edge, investing in the age of AI - Starpharma Chief Executive Officer, Cheryl Maley, joins Lel Smits from The Stock Network to discuss the opportunities in AI use in drug development and biotechnology.

🧬 Biotech in the age of AI
⚕️ Keeping patients and shareholders at the centre

Australian Shareholders’ Association Investor Summit
🗓 Mon 14 - Tue 15 September 2026
📍 The Langham Hotel, Gold Coast

What was the biggest trend coming from Fortescue Metals’ (ASX:FMG) results? Fortescue delivered strong FY26 results, underlying profit rising to US$3.5 billion and record iron ore shipments.

However, the standout trend in the commentary was AI moving into the heart of mining. Fortescue is already using AI across drilling, processing, rail and haulage, with the potential to cut costs and improve productivity.

Fortescue isn’t just digging up iron ore. It’s using technology to make mining smarter and cheaper, while continuing to invest in copper and renewable energy. AI is moving from the tech sector into mining, potentially changing how some of Australia’s biggest resource companies operate and make money.

#mining #AI #stocks #finktok #finance